# Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI

> **NCT02334904** · — · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 60 (estimated)

## Conditions studied

- First-Episode Psychosis
- Bipolar Disorder

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT02334904
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02334904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02334904, "Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02334904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*